Cargando…
F-18 PSMA Uptake in Male Breast Cancer during Restaging Evaluation of Carcinoma Prostate
Fluorine-18 prostate-specific membrane antigen (PSMA) positron emission tomography-computed tomography scan is widely used for restaging of prostate cancer. We present a case where false-positive PSMA uptake was seen in metachronous carcinoma breast during restaging workup of carcinoma prostate.
Autores principales: | Zade, Anand, Shetty, Shishir, Ambekar, Asawari, Karpe, Makarand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855249/ https://www.ncbi.nlm.nih.gov/pubmed/36686311 http://dx.doi.org/10.4103/ijnm.ijnm_127_21 |
Ejemplares similares
-
Usefulness of 18f-FDG PET-CT in Staging, Restaging, and Response Assessment in Pediatric Rhabdomyosarcoma
por: Donner, Davide, et al.
Publicado: (2020) -
Metastatic Thymic Carcinoma on Restaging 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography
por: Hoe Khoo, Alex Cheen, et al.
Publicado: (2020) -
Incidental Detection of Pseudomembranous Colitis Through (18)F-FDG PET/CT During the Restaging of Colorectal Cancer
por: Filippi, Luca
Publicado: (2023) -
Comparison of (68)Ga-PSMA PET/CT and (18)F-PSMA PET/CT of a Patient with Prostate Cancer Recurrence on Urinary Bladder Wall
por: Soydal, Çiğdem, et al.
Publicado: (2023) -
PSMA-Positive Low Malignant Gastrointestinal Stromal Tumor in the Stomach on F-18-PSMA-1007 PET/CT
por: Iversen, Peter, et al.
Publicado: (2022)